Durham.

PositionTriangle

DURHAM--BioCryst Pharmaceuticals boosted its research-and-development budget by $5 million to work on gout medicine. This year, it borrowed $23 million against royalty payments it expects from a Japanese drug maker for a flu treatment.

For a daily roundup of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT